Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:14:27 UTC |
---|
HMDB ID | HMDB0000017 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 4-Pyridoxic acid |
---|
Description | 4-Pyridoxic acid is a member of the class of compounds known as methylpyridines. More specifically it is a 2-methylpyridine derivative substituted by a hydroxy group at C-3, a carboxy group at C-4, and a hydroxymethyl group at C-5. 4-Pyridoxic acid is the catabolic product of vitamin B6 (also known as pyridoxine, pyridoxal and pyradoxamine) and is excreted in the urine. Urinary levels of 4-pyridoxic acid are lower in females than in males and will be reduced even further in persons with a riboflavin deficiency. 4-Pyridoxic acid is formed by the action of aldehyde oxidase I (an endogenous enzyme) and by microbial enzymes (pyridoxal 4-dehydrogenase), an NAD-dependent aldehyde dehydrogenase. 4-pyridoxic acid can be further broken down by the gut microflora via the enzyme known as 4-pyridoxic acid dehydrogenase. This enzyme catalyzes the four-electron oxidation of 4-pyridoxic acid to 3-hydroxy-2-methylpyridine-4,5-dicarboxylate, using nicotinamide adenine dinucleotide (NAD) as a cofactor. |
---|
Structure | CC1=NC=C(CO)C(C(O)=O)=C1O InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13) |
---|
Synonyms | Value | Source |
---|
2-Methyl-3-hydroxy-4-carboxy-5-hydroxymethylpyridine | ChEBI | 3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxylic acid | ChEBI | 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinic acid | ChEBI | 4-Pyridoxinecarboxylic acid | ChEBI | 4-Pyridoxinic acid | ChEBI | 4-Pyridoxinsaeure | ChEBI | 4-Pyridoxylic acid | ChEBI | Pyridoxic acid | ChEBI | 3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxylate | Generator | 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinate | Generator | 4-Pyridoxinecarboxylate | Generator | 4-Pyridoxinate | Generator | 4-Pyridoxylate | Generator | Pyridoxate | Generator | 4-Pyridoxate | Generator | 3-Hydroxy-5-(hydroxymethyl)-2-methyl-isonicotinate | HMDB | 3-Hydroxy-5-(hydroxymethyl)-2-methyl-isonicotinic acid | HMDB | 3-Hydroxy-5-hydroxymethyl-2-methyl-isonicotinate | HMDB | 3-Hydroxy-5-hydroxymethyl-2-methyl-isonicotinic acid | HMDB | 3-Hydroxy-5-hydroxymethyl-2-methyl-isonicotinsaeure | HMDB | 4 Pyridoxinic acid | MeSH, HMDB | Pyridoxinecarboxylic acid | MeSH, HMDB | 4 Pyridoxylic acid | MeSH, HMDB | 4 Pyridoxic acid | MeSH, HMDB |
|
---|
Chemical Formula | C8H9NO4 |
---|
Average Molecular Weight | 183.1614 |
---|
Monoisotopic Molecular Weight | 183.053157781 |
---|
IUPAC Name | 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid |
---|
Traditional Name | pyridoxic acid |
---|
CAS Registry Number | 82-82-6 |
---|
SMILES | CC1=NC=C(CO)C(C(O)=O)=C1O |
---|
InChI Identifier | InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13) |
---|
InChI Key | HXACOUQIXZGNBF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyridinecarboxylic acids. Pyridinecarboxylic acids are compounds containing a pyridine ring bearing a carboxylic acid group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Pyridinecarboxylic acids and derivatives |
---|
Direct Parent | Pyridinecarboxylic acids |
---|
Alternative Parents | |
---|
Substituents | - Pyridine carboxylic acid
- Hydroxypyridine
- Methylpyridine
- Vinylogous acid
- Heteroaromatic compound
- Azacycle
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Hydrocarbon derivative
- Alcohol
- Aromatic alcohol
- Organic nitrogen compound
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxide
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 247 - 248 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 4337 mg/L @ 25 °C (est) | The Good Scents Company Information System | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
4-Pyridoxic acid,1TMS,isomer #1 | CC1=NC=C(CO[Si](C)(C)C)C(C(=O)O)=C1O | 1856.0 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,1TMS,isomer #2 | CC1=NC=C(CO)C(C(=O)O[Si](C)(C)C)=C1O | 1837.4 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,1TMS,isomer #3 | CC1=NC=C(CO)C(C(=O)O)=C1O[Si](C)(C)C | 1805.1 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,2TMS,isomer #1 | CC1=NC=C(CO[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)=C1O | 1875.8 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,2TMS,isomer #2 | CC1=NC=C(CO[Si](C)(C)C)C(C(=O)O)=C1O[Si](C)(C)C | 1831.9 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,2TMS,isomer #3 | CC1=NC=C(CO)C(C(=O)O[Si](C)(C)C)=C1O[Si](C)(C)C | 1863.9 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,3TMS,isomer #1 | CC1=NC=C(CO[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)=C1O[Si](C)(C)C | 1952.4 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,1TBDMS,isomer #1 | CC1=NC=C(CO[Si](C)(C)C(C)(C)C)C(C(=O)O)=C1O | 2113.2 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,1TBDMS,isomer #2 | CC1=NC=C(CO)C(C(=O)O[Si](C)(C)C(C)(C)C)=C1O | 2099.9 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,1TBDMS,isomer #3 | CC1=NC=C(CO)C(C(=O)O)=C1O[Si](C)(C)C(C)(C)C | 2064.3 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,2TBDMS,isomer #1 | CC1=NC=C(CO[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)=C1O | 2330.2 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,2TBDMS,isomer #2 | CC1=NC=C(CO[Si](C)(C)C(C)(C)C)C(C(=O)O)=C1O[Si](C)(C)C(C)(C)C | 2338.8 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,2TBDMS,isomer #3 | CC1=NC=C(CO)C(C(=O)O[Si](C)(C)C(C)(C)C)=C1O[Si](C)(C)C(C)(C)C | 2350.0 | Semi standard non polar | 33892256 | 4-Pyridoxic acid,3TBDMS,isomer #1 | CC1=NC=C(CO[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)=C1O[Si](C)(C)C(C)(C)C | 2591.1 | Semi standard non polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - 4-Pyridoxic acid GC-MS (3 TMS) | splash10-0600-1594000000-399002a1b2bc22455c9f | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 4-Pyridoxic acid GC-MS (Non-derivatized) | splash10-0600-1594000000-399002a1b2bc22455c9f | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - 4-Pyridoxic acid GC-EI-TOF (Non-derivatized) | splash10-0002-0963000000-5ea1f1ffe15dc2478b63 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0uxr-0900000000-fa35397acddd7c3351b8 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (3 TMS) - 70eV, Positive | splash10-00c0-6029000000-e59f960993866934b8cc | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Pyridoxic acid GC-MS (TBDMS_3_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-001i-0900000000-4f9434fb63b0ad0ce994 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-014i-0900000000-99753fc7dd56422dd423 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-0002-0900000000-6e2e1f60d8bebc0b3340 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-0002-6900000000-8c038db01c62f9d4e87b | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-014i-9200000000-a94133cf31fe1f8b7938 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive-QTOF | splash10-00kb-0900000000-d57234d89d8c011abfb4 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, Positive-QTOF | splash10-00kb-7900000000-a99b8437514399d65aba | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative-QTOF | splash10-052r-0900000000-725f61f22b0bc1a28b93 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-IT , negative-QTOF | splash10-000i-0900000000-79e29b063e250dd7037b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QTOF , negative-QTOF | splash10-052r-0900000000-725f61f22b0bc1a28b93 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid , negative-QTOF | splash10-000i-0900000000-f82707706c2653c46393 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QQ , positive-QTOF | splash10-001i-0900000000-4f9434fb63b0ad0ce994 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QQ , positive-QTOF | splash10-014i-0900000000-2c70b549625fa141234a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QQ , positive-QTOF | splash10-0002-0900000000-2a37bda24c0b0f98132b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QQ , positive-QTOF | splash10-0002-6900000000-d3f955b006cc32330edd | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QQ , positive-QTOF | splash10-014i-9200000000-8f0fa7a53eb7325318ba | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QTOF , positive-QTOF | splash10-00kb-0900000000-d57234d89d8c011abfb4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid LC-ESI-QTOF , positive-QTOF | splash10-00kb-7900000000-a99b8437514399d65aba | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Pyridoxic acid , positive-QTOF | splash10-014i-0900000000-df0aa00e8733225ac266 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Pyridoxic acid 10V, Positive-QTOF | splash10-0159-0900000000-5860f1285218e1907916 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Pyridoxic acid 20V, Positive-QTOF | splash10-01ba-0900000000-463662790c3d6c47c8d1 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Pyridoxic acid 40V, Positive-QTOF | splash10-00di-6900000000-eda84db35c5bfbd25ceb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Pyridoxic acid 10V, Negative-QTOF | splash10-001r-0900000000-cdc1e6701650ec6b77f1 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Pyridoxic acid 20V, Negative-QTOF | splash10-0a4i-0900000000-fd70f5eeff9dec054259 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Pyridoxic acid 40V, Negative-QTOF | splash10-0a4i-7900000000-ff1dc4213c27146d1751 | 2017-09-01 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Feces
- Saliva
- Urine
|
---|
Tissue Locations | - Bladder
- Erythrocyte
- Kidney
- Liver
- Placenta
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.027 (0.0062-3.14) uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.040 +/- 0.007 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0071 +/- 0.005 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.0097 +/- 0.00665 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.00009-0.00300 uM | Children (1-13 years old) | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Infant (0-1 year old) | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Infant (0-1 year old) | Not Specified | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | > 0.33 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 0.78 +/- 0.45 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 3.1 (0.4-7.5) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 5.975 +/- 2.873 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 0.157 +/- 0.0613 umol/mmol creatinine | Children (1 - 13 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.245 +/- 0.0873 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.407 +/- 0.173 umol/mmol creatinine | Adolescent (13-18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 0.420 +/- 0.187 umol/mmol creatinine | Adolescent (13-18 years old) | Male | Normal | | details | Urine | Detected and Quantified | > 3.0 umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 2.99 +/- 5.25 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal adenoma | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Crohns disease | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Iron deficiency | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Both | Crohns disease | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Both | Ulcerative colitis | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Crohns disease | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Ulcerative colitis | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Unclassified IBD | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Urine | Detected and Quantified | 5.701 +/- 3.878 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected and Quantified | 1414.9 +/- 737.8 umol/mmol creatinine | Adult (>18 years old) | Both | Critically ill | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal adenoma | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Crohn's disease |
---|
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| Iron deficiency |
---|
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
| Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Ulcerative colitis |
---|
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB021874 |
---|
KNApSAcK ID | C00052160 |
---|
Chemspider ID | 6467 |
---|
KEGG Compound ID | C00847 |
---|
BioCyc ID | CPD-1112 |
---|
BiGG ID | 36190 |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | 239 |
---|
PubChem Compound | 6723 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 17405 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | 4PYRDX |
---|
MarkerDB ID | MDB00000008 |
---|
Good Scents ID | rw1699441 |
---|
References |
---|
Synthesis Reference | Senkuma, Masahiko; Imada, Katsumi; Sato, Masatada. Preparation of 4-pyridoxic acid. Jpn. Kokai Tokkyo Koho (1992), 2 pp. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Huang YC, Lan PH, Cheng CH, Lee BJ, Kan MN: Vitamin B6 intakes and status of mechanically ventilated critically ill patients in Taiwan. Eur J Clin Nutr. 2002 May;56(5):387-92. [PubMed:12001008 ]
- Kodentsova VM, Vrzhesinskaia OA, Sokol'nikov AA, Beketova NA, Spirichev VB: [The effect of riboflavin supply on metabolism of water-soluble vitamins]. Vopr Med Khim. 1993 Sep-Oct;39(5):29-33. [PubMed:8279138 ]
- Masse PG, Mahuren JD, Tranchant C, Dosy J: B-6 vitamers and 4-pyridoxic acid in the plasma, erythrocytes, and urine of postmenopausal women. Am J Clin Nutr. 2004 Oct;80(4):946-51. [PubMed:15447904 ]
- Huang YC, Chang HH, Huang SC, Cheng CH, Lee BJ, Cheng SY, Su KH: Plasma pyridoxal 5'-phosphate is a significant indicator of immune responses in the mechanically ventilated critically ill. Nutrition. 2005 Jul-Aug;21(7-8):779-85. [PubMed:15975484 ]
- Ericson KL, Mahuren JD, Zubovic YM, Coburn SP: Use of chlorite to improve HPLC detection of pyridoxal 5'-phosphate. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 5;823(2):218-20. [PubMed:16054880 ]
- Driskell JA, Chrisley BM: Plasma B-6 vitamer and plasma and urinary 4-pyridoxic acid concentrations in young women as determined using high performance liquid chromatography. Biomed Chromatogr. 1991 Sep;5(5):198-201. [PubMed:1742549 ]
- Chiang EP, Smith DE, Selhub J, Dallal G, Wang YC, Roubenoff R: Inflammation causes tissue-specific depletion of vitamin B6. Arthritis Res Ther. 2005;7(6):R1254-62. Epub 2005 Sep 13. [PubMed:16277678 ]
- Rybak ME, Pfeiffer CM: Clinical analysis of vitamin B(6): determination of pyridoxal 5'-phosphate and 4-pyridoxic acid in human serum by reversed-phase high-performance liquid chromatography with chlorite postcolumn derivatization. Anal Biochem. 2004 Oct 15;333(2):336-44. [PubMed:15450810 ]
- Huang YC, Chang SJ, Chiu YT, Chang HH, Cheng CH: The status of plasma homocysteine and related B-vitamins in healthy young vegetarians and nonvegetarians. Eur J Nutr. 2003 Apr;42(2):84-90. [PubMed:12638029 ]
- Midttun O, Hustad S, Solheim E, Schneede J, Ueland PM: Multianalyte quantification of vitamin B6 and B2 species in the nanomolar range in human plasma by liquid chromatography-tandem mass spectrometry. Clin Chem. 2005 Jul;51(7):1206-16. [PubMed:15976101 ]
- Chang SJ, Huang YC, Hsiao LJ, Lee YC, Hsuen SY: Determination of vitamin B-6 estimated average requirement and recommended dietary allowance for children aged 7-12 years using vitamin B-6 intake, nutritional status and anthropometry. J Nutr. 2002 Oct;132(10):3130-4. [PubMed:12368406 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|